Literature DB >> 24938894

Cell-penetrating peptide-mediated topical delivery of biomacromolecular drugs.

Jiao Tan, Heesun Cheong, Yoon Shin Park, Hangun Kim, Meng Zhang, Cheol Moon, Yongzhuo Huang1.   

Abstract

Biomacromolecules play an important role in the treatment of many diseases, but their topical application has been limited by their poor cell membrane permeability. Cell-penetrating peptides (CPPs) have been investigated over the past few decades as a potential strategy to overcome this challenge. CPPs can effectively mediate the cellular uptake of poorly internalized biomacromolecules without unfavorable side effects and have therefore attracted considerable interest as a viable alternative to existing parenteral therapies involving biomacromolecules. In this review, we will highlight the application of CPPs to the non-invasive delivery of biomacromolecules, with a focus on percutaneous and nasal absorption of biomacromolecules administered using CPPs.

Mesh:

Substances:

Year:  2014        PMID: 24938894     DOI: 10.2174/1389201015666140617094320

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  7 in total

1.  Prediction of Cell-Penetrating Potential of Modified Peptides Containing Natural and Chemically Modified Residues.

Authors:  Vinod Kumar; Piyush Agrawal; Rajesh Kumar; Sherry Bhalla; Salman Sadullah Usmani; Grish C Varshney; Gajendra P S Raghava
Journal:  Front Microbiol       Date:  2018-04-12       Impact factor: 5.640

Review 2.  Slp-coated liposomes for drug delivery and biomedical applications: potential and challenges.

Authors:  Gan Luo; Qingliang Yang; Bingpeng Yao; Yangfan Tian; Ruixia Hou; Anna Shao; Mengting Li; Zilin Feng; Wenxi Wang
Journal:  Int J Nanomedicine       Date:  2019-02-20

Review 3.  Strategies to Enhance Drug Absorption via Nasal and Pulmonary Routes.

Authors:  Maliheh Ghadiri; Paul M Young; Daniela Traini
Journal:  Pharmaceutics       Date:  2019-03-11       Impact factor: 6.321

4.  Cell Penetrating Peptide as a High Safety Anti-Inflammation Ingredient for Cosmetic Applications.

Authors:  Tse-Kai Fu; Ping-Hsueh Kuo; Yen-Chang Lu; Hsing-Ni Lin; Lily Hui-Ching Wang; Yu-Chun Lin; Yu-Chen Kao; Huey-Min Lai; Margaret Dah-Tsyr Chang
Journal:  Biomolecules       Date:  2020-01-07

Review 5.  Current Perspective on Nasal Delivery Systems for Chronic Rhinosinusitis.

Authors:  Junhu Tai; Kijeong Lee; Tae Hoon Kim
Journal:  Pharmaceutics       Date:  2021-02-10       Impact factor: 6.321

6.  Genetically-engineered "all-in-one" vaccine platform for cancer immunotherapy.

Authors:  Aihua Wu; Yingzhi Chen; Hairui Wang; Ya Chang; Meng Zhang; Pengfei Zhao; Yisi Tang; Qin Xu; Zhuangzhi Zhu; Yang Cao; Yongzhuo Huang
Journal:  Acta Pharm Sin B       Date:  2021-06-08       Impact factor: 11.413

7.  The Interaction between DNMT1 and High-Mannose CD133 Maintains the Slow-Cycling State and Tumorigenic Potential of Glioma Stem Cell.

Authors:  Yuanyan Wei; Qihang Chen; Sijing Huang; Yingchao Liu; Yinan Li; Yang Xing; Danfang Shi; Wenlong Xu; Weitao Liu; Zhi Ji; Bingrui Wu; Xiaoning Chen; Jianhai Jiang
Journal:  Adv Sci (Weinh)       Date:  2022-07-07       Impact factor: 17.521

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.